REMISSION WITH LUMATEPERONE 42 MG ADJUNCTIVE TO ANTIDEPRESSANT THERAPY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: ANALYSIS OF SHORT-TERM AND LONG-TERM TRIALS